CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 35 enrolled
Drug / intervention
Contrast sensitivityother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04972435
NCT04972435N/ACompleted

Effect of Multifocal Intraocular Lens on Contrast Sensitivity in Primary Angle-Closure Patients

Siriraj Hospital·interventional·Posted Jul 22, 2021·Updated Jul 30, 2021

In Brief

A clinical study evaluating Contrast sensitivity for Primary Angle Closure Glaucoma and 2 related conditions. Completed, enrolled 35 participants across 1 site.

Detailed Summary

This prospective study included patients with primary angle-closure (PAC or primary angle-closure glaucoma (PACG) and visually significant cataract. Phacoemulsification with multifocal intraocular lens (MIOL) or monofocal IOL (mIOL) (patient preference) was performed. Collected data included best-corrected distant visual acuity (BCVA), intraocular pressure (IOP), anterior chamber depth (ACD), and contrast sensitivity (CS) measured at spatial frequency 1.5, 3.0, 6.0, 12.0, and 18.0 cycles per degree (CPD) preoperatively, and at 2-6 months postoperatively. Preoperative and postoperative parameters were compared to evaluate the effect of MIOL on CS in eyes with PAC or PACG.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesThailand
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJul 22, 2021
Enrollment StartJan 2, 2014
Primary CompletionDec 30, 2015
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 4.9 years ago

Interventions

Contrast sensitivityother

All subjects performed the contrast sensitivity measurement preoperatively and one time at 2 months postoperatively.